Market Tracker

06/28 9:05am ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

111.89
Delayed Data
As of Jun 27
 -1.10 / -0.97%
Today’s Change
110.56
Today|||52-Week Range
208.88
-41.34%
Year-to-Date
How Does Brexit Impact Healthcare Stocks?
Jun 27 / Zacks.com - Paid Partner Content
3 Value Stocks Near 52-Week Lows Worth Buying
Jun 22 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks That Won't Pay a Dividend Anytime Soon, and 1 That Should
Jun 24 / MotleyFool.com - Paid Partner Content
Stock Market News for June 16, 2016
Jun 16 / Zacks.com - Paid Partner Content
RBC sees biopharma 'insulated' from Brexit, says buy Celgene for bounceback
Jun 24 / TheStreet.com - Paid Partner Content
3 Underdog Stocks We're Watching
Jun 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close112.99
Today’s open113.63
Day’s range111.02 - 115.39
Volume3,284,492
Average volume (3 months)1,765,534
Market cap$25.3B
Dividend yield--
Data as of 06/27/2016

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)+1.34%
Earnings growth (next 5 years)+22.28%
Revenue growth (last year)+12.25%
P/E ratio171.1
Price/Sales16.57
Price/Book3.09

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-1.09-2.34%
MYLMylan NV-1.75-4.02%
VRTXVertex Pharmaceutica...-2.06-2.52%
SHPGShire-1.39-0.84%
Data as of 06/27/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.18
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
Cheshire, Connecticut

Forecasts